Cell Growth & Differentiation, Vol 8, Issue 2 195-202, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation

H Miki, S Nonoyama, Q Zhu, A Aruffo, HD Ochs and T Takenawa
Department of Biochemistry, University of Tokyo, Japan.

Platelets are produced from megakaryocytes differentiated from megakaryoblasts, but the differentiation mechanism still remains unknown. Here, we demonstrate that a tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein (WASP), which is essential for megakaryocyte differentiation. MEG-01 megakaryoblastic cells differentiate into large multinucleated megakaryocyte-like cells characterized by microvesicle formation with a protein kinase C (PKC) activator, 12-O-tetradecanoylphorbol 13-acetate. With parallel to the differentiation, WASP begins to accumulate at microvesicles with actin filaments and associates with tyrosine-phosphorylated Shc, the phosphorylation of which is induced. Moreover, a tyrosine kinase inhibitor, herbimycin A, blocked not only phosphorylation of Shc but also microvesicle formation without affecting cell enlargement and multinucleation, whereas a PKC inhibitor, H-7, completely inhibited all these processes. Because WASP also binds to Ash/Grb2 SH3 domains and the association of Ash/Grb2 and Shc is induced by 12-O-tetradecanoylphorbol 13-acetate treatment, a signaling pathway, PKC-tyrosine kinase-Shc-Ash/Grb2-WASP, is suggested for regulating megakaryocyte differentiation. In addition, WASP antisense oligonucleotide treatment abolishes both microvesicle formation and gathering of actin filaments. These data clearly show that WASP controls the assembly of actin filaments required for microvesicle formation downstream of PKC-tyrosine kinase.

This article has been cited by other articles:

				J. Withee, B. Galligan, N. Hawkins, and G. Garriga Caenorhabditis elegans WASP and Ena/VASP Proteins Play Compensatory Roles in Morphogenesis and Neuronal Cell Migration Genetics, July 1, 2004; 167(3): 1165 - 1176. [Abstract] [Full Text] [PDF]

				P. Rojnuckarin and K. Kaushansky Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase C{alpha} Blood, January 1, 2001; 97(1): 154 - 161. [Abstract] [Full Text] [PDF]

				W. H. Raskind, K. K. Niakan, J. Wolff, M. Matsushita, T. Vaughan, G. Stamatoyannopoulos, C. Watanabe, J. Rios, and H. D. Ochs Mapping of a syndrome of X-linked thrombocytopenia with thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia Blood, April 1, 2000; 95(7): 2262 - 2268. [Abstract] [Full Text] [PDF]

				B. S. Gross, J. I. Wilde, L. Quek, H. Chapel, D. L. Nelson, and S. P. Watson Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI Blood, December 15, 1999; 94(12): 4166 - 4176. [Abstract] [Full Text] [PDF]

				A. Shcherbina, F. S. Rosen, and E. Remold-O'Donnell WASP Levels in Platelets and Lymphocytes of Wiskott-Aldrich Syndrome Patients Correlate with Cell Dysfunction J. Immunol., December 1, 1999; 163(11): 6314 - 6320. [Abstract] [Full Text] [PDF]

				J. Zhang, A. Shehabeldin, L. A.G. da Cruz, J. Butler, A.-K. Somani, M. McGavin, I. Kozieradzki, A. O. dos Santos, A. Nagy, S. Grinstein, et al. Antigen Receptor-induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein-deficient Lymphocytes J. Exp. Med., November 1, 1999; 190(9): 1329 - 1342. [Abstract] [Full Text] [PDF]

				M. Kato, H. Miki, K. Imai, S. Nonoyama, T. Suzuki, C. Sasakawa, and T. Takenawa Wiskott-Aldrich Syndrome Protein Induces Actin Clustering without Direct Binding to Cdc42 J. Biol. Chem., September 17, 1999; 274(38): 27225 - 27230. [Abstract] [Full Text] [PDF]

				E. Haddad, E. Cramer, C. Riviere, P. Rameau, F. Louache, J. Guichard, D. L. Nelson, A. Fischer, W. Vainchenker, and N. Debili The Thrombocytopenia of Wiskott Aldrich Syndrome Is Not Related to a Defect in Proplatelet Formation Blood, July 15, 1999; 94(2): 509 - 518. [Abstract] [Full Text] [PDF]

				C. K. Miranti, S. Ohno, and J. S. Brugge Protein Kinase C Regulates Integrin-induced Activation of the Extracellular Regulated Kinase Pathway Upstream of Shc J. Biol. Chem., April 9, 1999; 274(15): 10571 - 10581. [Abstract] [Full Text] [PDF]

				Y. Baba, S. Nonoyama, M. Matsushita, T. Yamadori, S. Hashimoto, K. Imai, S. Arai, T. Kunikata, M. Kurimoto, T. Kurosaki, et al. Involvement of Wiskott-Aldrich Syndrome Protein in B-Cell Cytoplasmic Tyrosine Kinase Pathway Blood, March 15, 1999; 93(6): 2003 - 2012. [Abstract] [Full Text] [PDF]

				T. Nakamura, S. Muraoka, R. Sanokawa, and N. Mori N-Shc and Sck, Two Neuronally Expressed Shc Adapter Homologs. THEIR DIFFERENTIAL REGIONAL EXPRESSION IN THE BRAIN AND ROLES IN NEUROTROPHIN AND Src SIGNALING J. Biol. Chem., March 20, 1998; 273(12): 6960 - 6967. [Abstract] [Full Text] [PDF]

				Y. Wu, S. D. Spencer, and L. A. Lasky Tyrosine Phosphorylation Regulates the SH3-mediated Binding of the Wiskott-Aldrich Syndrome Protein to PSTPIP, a Cytoskeletal-associated Protein J. Biol. Chem., March 6, 1998; 273(10): 5765 - 5770. [Abstract] [Full Text] [PDF]